Broken Trust: Product Liability for Medicines and Medical Devices

05 October 2026

When a medicine or medical device causes harm, determining who is legally responsible is rarely straightforward. Unlike ordinary consumer products, pharmaceuticals and medical devices involve complex questions of causation, regulation, medical judgment and delayed harm.

In 2026, product liability for medical products is entering a significant period of change across the United States, European Union, United Kingdom and India. From evolving mass-tort litigation in the US to major reforms in the EU, a review of the UK’s long-standing product safety framework and India’s proposed overhaul of its drugs and medical-device regime, the legal landscape is shifting rapidly.

Our latest publication examines these developments comparatively, exploring how each jurisdiction approaches defective medicines and medical devices, manufacturer liability, regulatory compliance, causation and access to remedies.

Enlarge View & Download

News & Deals

India Juris Signs MoU with NLU Meghalaya

India Juris Supports USD 7 Million Series A Funding

India Juris Supports USD 2.5 Million Seed Investment in AI

Publications

Children’s Data and Verifiable Parental Consent

Comparative Energy Security – China and India

Setting Up a Fund in GIFT City, IFSC

Newsletters

SEBI Revises Credit Risk & Trustee Compliance Norms

Product Liability & Regulatory Developments

DPDP Act: Key Compliance Updates